Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer

Clinical trial NCT00009984 · TERMINATED

Trial details

NCT number: NCT00009984
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia

Start date: 2002-03-01
Primary completion: 2006-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.